Paul K. Wotton
2010
In 2010, Paul K. Wotton earned a total compensation of $756.8K as Chief Executive Officer at Antares Pharma, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $116,526 |
| Salary | $390,000 |
| Stock Awards | $82,000 |
| Other | $8,250 |
| Total | $756,776 |
Wotton received $390K in salary, accounting for 52% of the total pay in 2010.
Wotton also received $160K in non-equity incentive plan, $116.5K in option awards, $82K in stock awards and $8.3K in other compensation.
Rankings
In 2010, Paul K. Wotton's compensation ranked 6,284th out of 10,439 executives tracked by ExecPay. In other words, Wotton earned more than 39.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,284 out of 10,439 | 40th |
Division Manufacturing | 2,270 out of 3,838 | 41st |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 340 out of 667 | 49th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 169 out of 373 | 55th |
Industry Surgical and Medical Instruments and Apparatus | 94 out of 240 | 61st |
Source: SEC filing on April 12, 2013.
Wotton's colleagues
We found three more compensation records of executives who worked with Paul K. Wotton at Antares Pharma in 2010.